ZGNX Key Stats
- Zogenix and Battelle to Present Positive, New Data Demonstrating Value of Needle... May 20
- Did These Healthcare Stocks Miss or Beat Analyst Expectations? May 12
- Impax Labs (IPXL), Zogenix (ZGNX) Rise as FDA Won't Block Generic Opana (ENDP) Street Insider May 10
- Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin May 10
- Zogenix's CEO Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha May 9
- Zogenix Earnings: Here’s Why Investors are Selling Shares Now May 9
- Zogenix, Inc. Earnings Call scheduled for 4:30 pm ET today May 9
- Zogenix, Inc. (ZGNX) Posts Q1 Loss of 21c/Share Street Insider May 9
- Zogenix Reports First Quarter 2013 Financial Results GlobeNewswire May 9
- ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 9
ZGNX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Zogenix is down 7.83% over the last year vs S&P 500 Total Return up 27.96%, Johnson & Johnson up 42.25%, and GlaxoSmithKline up 25.97%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for ZGNX
Pro Report PDF for ZGNX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ZGNX Pro Report PDF
Pro Strategies Featuring ZGNX
Did Zogenix make it into our Pro Portfolio Strategies?